Stockscreener 앱 받기
7.36
0.27%
-0.02
시간 외 거래:
7.46
0.10
+1.36%
Instil Bio Inc 주식(TIL)의 최신 뉴스
Why (TIL) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Instil Bio, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Form 8K Instil Bio Inc For: 13 August By Investing.com - Investing.com Nigeria
Instil Bio Reports Second Quarter 2026 Financial Results - Intellectia AI
Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
Instil Bio Reports $4.3 Million Second-Quarter 2026 Net Loss - Quiver Quantitative
Instil Bio, Inc. 2026: Revenue ($4.35M), Net income ($4.3M), EPS ($0.63) — 10-Q Summary - TradingView
Instil Bio reports Q2 2026 net loss $4.3M, cash and marketable securities $69.9M - TradingView
Instil Bio (TIL) slashes R&D spend and leans on Tarzana lease income in Q2 2026 - Stock Titan
Instil Bio expects $69.9M cash to fund plan beyond 2027 - Stock Titan
Instil Bio (Nasdaq: TIL) trims Q2 2026 loss and extends cash runway - Stock Titan
Instil Bio Inc (TIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Instil Bio, Inc. (TIL) And Encourages Investors to Connect - The National Law Review
Instil Bio, Inc. expected to post a loss of 43 cents a shareEarnings Preview - TradingView
Instil Bio Inc (TIL) Stock News Today - TradingKey
Instil Bio Q1 2026 Earnings: EPS Miss Reflects Continued Pre-Clinical-Stage InvestmentInvestor Earnings Call - dars.gov.et
TIL Q2'26 Earnings: revenue estimate is 0 USD - TradingView
Instil Bio (TIL) Edges Lower Near Key Support LevelsPassive Flow - dars.gov.et
Instil Bio Inc (TIL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TIL|Instil Bio Inc|Price:7.380|Chg%:-0.030 - TradingKey
Instil Bio Inc (TIL) Balance Sheet - TradingKey
Instil Bio Inc (TIL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Instil Bio Inc (TIL) Income Statement - TradingKey
Instil Bio Inc (TIL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TIL|Instil Bio Inc|Price:7.130|Chg%:-0.070 - TradingKey
Instil Bio Inc (TIL) Cash Flow - TradingKey
Instil Bio, Inc. Revenue Breakdown – NASDAQ:TIL - TradingView
TIL|Instil Bio Inc|Price:7.380|Chg%:+0.110 - TradingKey
Instil Bio Inc (TIL) Institutional Confidence - TradingKey
Instil Bio Inc (TIL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Avoiding Lag: Real-Time Signals in (TIL) Movement - Stock Traders Daily
TIL Q1 2026 Earnings: Wider-Than-Expected Loss Amid Preclinical Pipeline ActivityEarnings Preview - dars.gov.et
Instil Bio Inc. (TIL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Reports Wider Loss - DonanımHaber
Instil Bio (TIL) edges higher as shares test key support-resistance rangeTriangle Correction - DonanımHaber
Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (TIL) Investors to Inquire about Securities Investigation - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (T - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Discipline and Rules-Based Execution in TIL Response - Stock Traders Daily
Enterprise value to EBIT forward of Instil Bio, Inc. – NASDAQ:TIL - TradingView
Price to book forward of Instil Bio, Inc. – NASDAQ:TIL - TradingView
Price to sales forward of Instil Bio, Inc. – NASDAQ:TIL - TradingView
Price to earnings forward of Instil Bio, Inc. – NASDAQ:TIL - TradingView
TIL Q1 2026 Earnings: EPS Miss Reflects Increased R&D Spend as Pipeline AdvancesOne-Time Gain Impact - dars.gov.et
Instil Bio, Inc. Actuals & Estimates (NASDAQ:TIL) - TradingView
5GT0 Forecast — Price Target — Prediction for 2027 - TradingView
TIL Forecast — Price Target — Prediction for 2027 - TradingView
Instil Bio Q1 2026 Earnings: Wider-Than-Expected Loss, Stock Edges LowerSaaS Earnings Trends - dars.gov.et
Instil Bio Inc (TIL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Instil Bio Q1 2026 Earnings: Narrow EPS Miss, No Revenue, and Modest Stock UptickNet Income Trends - dars.gov.et
Instil Bio Inc (TIL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Behavioral Patterns of TIL and Institutional Flows - Stock Traders Daily
TIL Should I Buy - intellectia.ai
Instil Bio Inc (TIL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Instil Bio (TIL) director awarded stock options for 6,500 shares at $7.93 - Stock Titan
Instil Bio (NASDAQ: TIL) director receives grant of 6,500 stock options - Stock Titan
Instil Bio (TIL) director awarded 6,500 stock options at $7.93 strike - Stock Titan
Instil Bio (TIL) director Gwendolyn Binder awarded 6,500 stock options at $7.93 - Stock Titan
1.80%
1.77%
자본화:
|
볼륨(24시간):